Richard A Miller Md insider trades

Open-market stock purchases and sales by Richard A Miller Md, President and CEO at Corvus Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 22, 2016.

Track record: 92% of 24 scored buys are up 5% or more since purchase, averaging +130%.

Recent trades

DateStockTradeValue
May 18, 2026CRVS Corvus Pharmaceuticals, IncBought$60.3K
May 18, 2026CRVS Corvus Pharmaceuticals, IncBought$23.2K
Dec 4, 2025CRVS Corvus Pharmaceuticals, IncBought (not open market)—

Companies traded

  • CRVS Corvus Pharmaceuticals, Inc: 41 buys, last May 18, 2026
  • BOLT Bolt Biotherapeutics, Inc: other filings, last Jun 12, 2023

Get free alerts when Richard A Miller Md files a new trade →